Journal article

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

Kit N Simpson, Annie N Simpson, Patrick D Mauldin, Yuko Y Palesch, Sharon D Yeatts, Dawn Kleindorfer, Thomas A Tomsick, Lydia D Foster, Andrew M Demchuk, Pooja Khatri, Michael D Hill, Edward C Jauch, Tudor G Jovin, Bernard Yan, Ruediger von Kummer, Carlos A Molina, Mayank Goyal, Wouter J Schonewille, Mikael Mazighi, Stefan T Engelter Show all

Journal of the American Heart Association | WILEY | Published : 2017

Grants

Awarded by NIH/NINDS


Awarded by Medical University of South Carolina through NIH-NCATS


Awarded by Alberta Innovates


Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES


Funding Acknowledgements

This work was supported by NIH/NINDS grant numbers: UC U01NS052220, U01NS054630, and U01NS077304. Genentech Inc supplied study drug used for intra-arterial tPA in the Endovascular group. EKOS Corp, Concentric Inc, and Cordis Neurovascular, Inc supplied study catheters during Protocol Versions 1 to 3. In the United States, IMS III investigator meeting support was provided, in part, by Genentech Inc, EKOS Corp, and Concentric Inc. In Europe, IMS III investigator meeting support was provided, in part, by Boehringer Ingelheim. This publication was partially supported by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, through NIH-NCATS Grant Number UL1 TR001450. Data support for the study was provided through the CEDAR core funded by the MUSC Office of the Provost.